NLRP3 and Hypertension: Currently, studies on the impact of TGF-beta-mediated inflammation on renal diseases are mainly focused on hypertension (Felix et al., 2019; Southgate et al., 2019), and reports on TGF-beta-mediated NLRP3 inflammasomes and renal fibrosis are limited.